Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3 Pt 1
pubmed:dateCreated
1996-2-23
pubmed:abstractText
Three groups of patients in treatment were assessed for impotence, using MMPI-derived Impotence Scale. Group I were 46 patients who had been screened and scheduled for a penile prosthesis when the impotence resulted from known organic causes (biogenic). Group II were 198 patients in a sexual dysfunction clinic, for whom biogenic causes had been ruled out (psychogenic). Group III were 51 substance abusers in drug rehabilitation. While scores on the Impotence Scale did not distinguish between the biogenic and psychogenic groups, the scores were almost three times higher than average scores among subjects in the standardization sample. MMPI-derived Impotence Scale scores were similarly elevated among the substance abusers. Results suggest that the Impotence Scale may serve as a useful screening tool to alert clinicians to the possibility of erectile dysfunction for which further clinical evaluation would be required.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0033-2941
pubmed:author
pubmed:issnType
Print
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1019-26
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Psychological screening of impotence with Finney's MMPI-derived Impotence Scale.
pubmed:affiliation
Drug Abuse Program, West Side VA Medical Center, Chicago, IL 60612-3740, USA.
pubmed:publicationType
Journal Article